Physician profile
Rabinder Bhogal
NPI 1194730994
$2,355.11
in general payments reported to CMS, 2019-2025
18 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $36.91 · 2021: $304 · 2022: $425 · 2023: $613 · 2024: $298 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $821.25 | 2019-2025 | Skyrizi, Rinvoq, Linzess |
| Boston Scientific Corporation | $348.70 | 2022-2025 | Axios |
| Celgene Corporation | $341.14 | 2021-2023 | Zeposia |
| Daiichi Sankyo INC. | $192.39 | 2019-2023 | Injectafer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $149.36 | 2019-2024 | Xifaxan |
| Gilead Sciences, INC. | $127.96 | 2019-2025 | |
| Janssen Biotech, INC. | $114.17 | 2019 | |
| Merck Sharp & Dohme LLC | $44.35 | 2023 | Dificid |
| Pfizer INC. | $32.56 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.46 | 2025 | Entyvio |
| Shionogi INC | $25.62 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $25.10 | 2023-2024 | Eyemax, Dat Closure Device |
| Albireo Pharma, INC. | $18.71 | 2024 | Bylvay |
| Intercept Pharmaceuticals, INC. | $17.70 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.18 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $17.01 | 2023 | Terlivaz |
| Redhill Biopharma INC. | $14.75 | 2021 | |
| Olympus America INC. | $14.70 | 2024 | Evis X1 Video System Center |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rabinder Bhogal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.